Company Overview - Blade Air Mobility, Inc. is changing its legal name to Strata Critical Medical, Inc. to focus on mission-critical logistics and medical services for hospitals and healthcare providers [1][2] - The company is one of the largest transporters of human organs for transplant in the United States and provides air transportation and logistics services primarily in the Northeast United States, Southern Europe, and Western Canada [3] Stock Information - The name change will take effect on August 28, 2025, and the company's common stock will begin trading under the symbol "SRTA" on August 29, 2025 [2] - The CUSIP numbers for the company's common stock and warrants will remain unchanged, and no action is required from securityholders [2] Business Model - Blade operates an asset-light model with exclusive passenger terminal infrastructure and proprietary technologies, facilitating a transition to Electric Vertical Aircraft (EVA or eVTOL) for lower-cost, quiet, and emission-free air mobility [3]

Company Overview - Blade Air Mobility, Inc. is a technology-powered air mobility platform that provides air transportation and logistics for hospitals across the United States, being one of the largest transporters of human organs for transplant [2] - The company offers helicopter and fixed-wing services primarily in the Northeast United States and Southern Europe, operating an asset-light model with exclusive passenger terminal infrastructure and proprietary technologies [2] Upcoming Events - The Chief Financial Officer, Will Heyburn, will present at the Oppenheimer 28th Annual Technology, Internet & Communications Conference on August 11, 2025, at 2:55 PM ET, with a webcast available for investors [1] Business Model and Technology - Blade's model is designed to facilitate a seamless transition from traditional aircraft to Electric Vertical Aircraft (EVA or eVTOL), aiming for lower-cost air mobility that is both quiet and emission-free [2]

Core Viewpoint - Blade Air Mobility, Inc. has announced the sale of its passenger division to Joby Aviation for up to $125 million, allowing Blade to focus on its medical logistics business, which will rebrand as Strata Critical Medical [1][9][10]. Company Overview - Blade Air Mobility provides air transportation and logistics, primarily for hospitals in the U.S., and is one of the largest transporters of human organs for transplant [12]. - Joby Aviation is developing an all-electric vertical take-off and landing air taxi service, intending to operate and sell its aircraft globally [14]. Transaction Details - The sale price for the passenger division is up to $125 million, which may be paid in cash or Joby stock, including up to $35 million in performance-based earnouts [10]. - The transaction is expected to close in the coming weeks, with a new ticker for Strata to be announced later [11]. Strategic Focus Post-Transaction - Following the divestiture, Strata will concentrate on its medical logistics and services, leveraging its asset-light platform to enhance its offerings and pursue growth through acquisitions [2][8]. - The medical division represented approximately 84% of Blade's Segment Adjusted EBITDA and 59% of its revenue in 2024, indicating a strong focus on this profitable segment [8]. Leadership Changes - Rob Wiesenthal, the current CEO of Blade, will join Joby as CEO of Blade Air Mobility and serve as Chairman of Strata [5]. - Will Heyburn and Melissa Tomkiel will become Co-CEOs of Strata while retaining their existing roles [6]. Partnership and Future Opportunities - A long-term partnership between Joby and Strata will provide access to Joby aircraft for medical use, enhancing Strata's service capabilities [4][9]. - The expected operational efficiencies from the divestiture are estimated at approximately $7 million annually, making the financial impact neutral in terms of Adjusted EBITDA and Free Cash Flow [5][9].

Company Overview - Blade Air Mobility, Inc. is a provider of air transportation and logistics services, primarily for hospitals and passengers in the United States and Southern Europe [3] - The company is one of the largest transporters of human organs for transplant and offers helicopter and fixed-wing services [3] - Blade operates an asset-light model with exclusive passenger terminal infrastructure and proprietary technologies, facilitating a transition to Electric Vertical Aircraft (EVA or eVTOL) for lower-cost, quiet, and emission-free air mobility [3] Upcoming Financial Results - Blade will release its financial results for the second quarter ended June 30, 2025, on August 5, 2025, before the market opens [1] - A conference call will be held on the same day at 8:00 am Eastern Time, hosted by the CEO and CFO, including a question-and-answer session [1][2]

Company Overview - Blade Air Mobility, Inc. is a technology-powered air mobility platform that provides air transportation and logistics for hospitals across the United States, being one of the largest transporters of human organs for transplant [2] - The company offers helicopter and fixed-wing services primarily in the Northeast United States and Southern Europe, operating an asset-light model with exclusive passenger terminal infrastructure and proprietary technologies [2] Upcoming Events - Rob Wiesenthal, the CEO of Blade, will present at the Ladenburg Thalmann Technology Innovation Expo 25 on May 21, 2025, at 3:00 PM ET, with a webcast available for investors [1] Business Model and Technology - Blade's model is designed to facilitate a seamless transition from traditional helicopters and fixed-wing aircraft to Electric Vertical Aircraft (EVA or eVTOL), aiming for lower-cost air mobility that is both quiet and emission-free [2]

Company Overview - Blade Air Mobility, Inc. is a technology-powered air mobility platform that provides air transportation and logistics for hospitals across the United States, being one of the largest transporters of human organs for transplant [2] - The company offers helicopter and fixed-wing services primarily in the Northeast United States and Southern Europe, operating an asset-light model with exclusive passenger terminal infrastructure and proprietary technologies [2] Upcoming Events - Mat Schneider, Vice President of Investor Relations and Strategic Finance, will present at the 2025 J.P. Morgan Annual Global Technology, Media, and Communications Conference on May 14, 2025, at 3:40 PM ET [1] Business Model and Technology - Blade's model is designed to facilitate a seamless transition from helicopters and fixed-wing aircraft to Electric Vertical Aircraft (EVA or eVTOL), aiming for lower-cost air mobility that is both quiet and emission-free [2]